True Bearing Preps for Multi-Site Validation Trial in Pivot to Infectious Disease Detection
The company had to step back from an initial focus on cardiovascular disease but believes its new target will have an easier path to market.
The company had to step back from an initial focus on cardiovascular disease but believes its new target will have an easier path to market.
